Y. Hayashi, “Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis”, J Hematol, Jan. 2025, doi: 10.14740/jh2010.